Western blot analysis showed that, in the progression of human prostate cancer cells from least aggressive (LNCaP cells) to most aggressive (C4-2B cells), a progressive increase occurs in the intensity of staining for GLS1 relative to that of β-actin (Figure 1). The gene discussed is GLS; the disease is Familial prostate cancer.